ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $339,000 | -21.9% | 9,240 | -0.9% | 0.01% | -22.2% |
| Q2 2019 | $434,000 | -8.1% | 9,324 | -20.7% | 0.01% | -10.0% |
| Q1 2019 | $472,000 | -9.9% | 11,760 | +3.2% | 0.01% | -23.1% |
| Q4 2018 | $524,000 | -14.0% | 11,396 | -16.9% | 0.01% | +8.3% |
| Q3 2018 | $609,000 | +757.7% | 13,720 | +653.8% | 0.01% | +500.0% |
| Q2 2018 | $71,000 | -94.4% | 1,820 | -89.7% | 0.00% | -93.1% |
| Q1 2018 | $1,278,000 | +353.2% | 17,668 | +312.4% | 0.03% | +383.3% |
| Q4 2017 | $282,000 | -24.0% | 4,284 | -42.0% | 0.01% | -33.3% |
| Q3 2017 | $371,000 | -3.4% | 7,392 | -10.8% | 0.01% | 0.0% |
| Q2 2017 | $384,000 | -1.8% | 8,288 | -25.3% | 0.01% | -10.0% |
| Q1 2017 | $391,000 | +181.3% | 11,088 | 0.0% | 0.01% | +150.0% |
| Q4 2016 | $139,000 | – | 11,088 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |